Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial.

Keywords : ['type diabetes mellitus inadequately control', 'randomise control trial', 'metformin alone', 'saxagliptin', 'patient', 'noninferior', 'glipizide']
Author : B Göke
22

Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Keywords : ['randomize doubleblind placebocontrolle trial', 'pantoprazole improve glycemic control', 'type diabetes']
Author : PK Singh
22

Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Keywords : ['randomize doubleblind placebocontrolle trial', 'pantoprazole improve glycemic control', 'type diabetes']
Author : PK Singh
22

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.

Keywords : ['liraglutide versus placebo add', 'randomized placebocontrolle trial', 'basal insulin analogue', 'without metformin', 'type diabetes', 'safety', 'patient', 'efficacy']
Author : A Ahmann
22

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.

Keywords : ['liraglutide versus placebo add', 'randomized placebocontrolle trial', 'basal insulin analogue', 'without metformin', 'type diabetes', 'safety', 'patient', 'efficacy']
Author : A Ahmann
22

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.

Keywords : ['liraglutide versus placebo add', 'randomized placebocontrolle trial', 'basal insulin analogue', 'without metformin', 'type diabetes', 'safety', 'patient', 'efficacy']
Author : A Ahmann
22

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.

Keywords : ['liraglutide versus placebo add', 'randomize placebocontrolle trial', 'basal insulin analogue', 'without metformin', 'type diabete', 'safety', 'patient', 'efficacy']
Author : A Ahmann
22